Michael Shalmi

<i>N</i>-Substituted Adenosines as Novel Neuroprotective A₁ Agonists with Diminished Hypotensive Effects

Lars J. S. Knutsen, Jesper Lau, Hans Petersen et al. · Journal of Medicinal Chemistry · 1999 · 67 citations · Full text

Medicine, Neuroscience, Pharmacology +13

Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits.

Pernille Holm, Niels Korsgaard, Michael Shalmi et al. · Journal of Clinical Investigation · 1997 · 64 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Renal response to furosemide in conscious rats: effects of acute instrumentation and peripheral sympathectomy.

J. S. Petersen, Michael Shalmi, Ho Lam et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 62 citations

Medicine, Nephrology, Pharmacology +17

Norethindrone Acetate Enhances the Antiatherogenic Effect of 17β-Estradiol

Peter Alexandersen, Jens Haarbo, Irene Sandholdt et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1998 · 41 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

A Partial Estrogen Receptor Agonist With Strong Antiatherogenic Properties Without Noticeable Effect on Reproductive Tissue in Cholesterol-Fed Female and Male Rabbits

Pernille Holm, Michael Shalmi, Niels Korsgaard et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1997 · 34 citations · Full text

Medicine, Endocrinology, Pharmacology +13